Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin treatment in moderate to severe aspirin-sensitive asthma
IRCT2015061521970N2Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aspirin in asthma, chronic rhinosinusitis (CRS) and chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Iran University of Medical Sciences. Started Jul 2015; status: completed.
02
Drugs
aspirin
03
Conditions
asthmachronic rhinosinusitis (CRS)chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT2015061521970N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015061521970N2.